Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Peripheral neuropathy: a condition that can cause tingling, numbness, and pain in the extremities, especially the feet and ...

The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced perip ...

NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced ...

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

In a healthcare industry that has become inundated with physicians who overprescribe pain medication and are all too eager to ...